Back

Cilostazol restores endothelial function and reduces platelet hyperactivity via PKA/ENOS/PKG and NRF2 signaling in experimental metabolic syndrome

31 August 2026 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Adipose tissue, metabolic syndrome, and cardiometabolic disease Lipid Metabolism, Metabolic Syndrome, Diabetes ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Gabriel Lima

University of Strasbourg, Strasbourg (France)

5 More presentations in this session

Presentation thumbnail
Inflammatory epicardial adipose tissue–myocardial crosstalk in coronary artery disease: a single-cell analysis
Doctor S. Doppler (Munich, DE)
Abstract
Presentation thumbnail
Triple GLP-1R/GIP-R/GCGR activation synergistically suppresses macrophage-driven oxidative stress and activation in human epicardial adipose tissue from patients with a history of atrial fibrillation
Doctor W. Fakih (Strasbourg, FR)
Abstract
Presentation thumbnail
Transcriptomic profiling of dysfunctional adipose tissue defines biomarker signatures that improve diabetes risk assessment
Doctor O. Brown (Leeds, GB)
Abstract
Presentation thumbnail
Associations between glucolipid metabolic indices with the risk and progression of cardiovascular-kidney-metabolic syndrome in MASLD: evidence from the UK biobank
Mr R. Wang (Beijing, CN)
Abstract
Presentation thumbnail
Skeletal muscle acts as a major organ for systemic oxidized LDL clearance via a CD36-dependent mechanism enhanced by physical exercise.
Professor T. Sawamura (Matsumoto, JP)
Abstract

Access the full session

Session thumbnail
Adipose tissue, metabolic syndrome, and cardiometabolic disease

The Event

Event poster

ESC Congress 2026

31 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Metabolic syndrome contributes to the pulmonary arterial dysfunction in pulmonary hypertension in heart failure with preserved ejection fraction
31 August 2020
thumbnail
Congress Presentation
Optimizing post-PCI therapy: ticagrelor, prasugrel, clopidogrel, and cilostazol reduce early MACE
21 March 2026
thumbnail
Congress Presentation
Influence of phospholipase A2 and paraoxonase activity on endothelial function changes in various forms of coronary artery disease
15 April 2021
thumbnail
Congress Presentation
Role of phosphodiesterases in the development of takotsubo syndrome
1 September 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources